Polyamine transport as a target for treatment of Pneumocystis pneumonia

Chung Ping Liao, Otto Phanstiel IV, Mark E. Lasbury, Chen Zhang, Shoujin Shao, Pamela J. Durant, Bi Hua Cheng, Chao-Hung Lee

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Polyamine levels are greatly increased in alveolar macrophages (AMs) during Pneumocystis pneumonia (PCP), leading to increased production of H 2O2, which causes AMs to undergo apoptosis. One of the mechanisms by which polyamine levels in AMs are elevated is enhanced uptake of exogenous polyamines. In this study, the possibility of targeting polyamine uptake as a treatment for PCP was examined. Four anthracene- and one benzene-polyamine conjugates that are potential polyamine transport inhibitors, including N1-anthracen-9-ylmethyl-butane-1,4-diamine; N-(4-aminobutyl)-N- anthracen-9-ylmethylbutane-1,4-diamine; N-[4-(4-aminobutylamino) butyl]-N-anthracen-9-ylmethylbutane-1,4-diamine; N-(4-amino-butyl)-N′-(10- {[4-(4-aminobutylamino) butylamino]-methyl}anthracen-9-ylmethyl)butane-1,4- diamine (44-Ant-44); and benzene-polyamine conjugate N-(4-amino-butyl)-N′- (4-{[4-(4-amino-butylamino)butylamino]-methyl}benzyl)butane-1,4-diamine (44-Bn-44), were tested. Compounds 44-Ant-44 and 44-Bn-44 were found to have a very low toxicity to AMs in vitro and were evaluated for their therapeutic effect on PCP in vivo. Sprague-Dawley rats infected with P. carinii for 28 days were intranasally instilled with 50 μl of a 1 mMsolution of 44-Bn-44 or 44-Ant-44 every 2 days. Twenty-one days after initiation of the treatment, three to five rats from each group were sacrificed and examined for lung pathology, organism burden, and apoptosis of AMs. Both 44-Bn-44 and 44-Ant-44 reduced organism burdens; however, only 44-Ant-44 decreased the severity of the infection with reduced lung inflammation, increased clearance of exudates, increased air space, and decreased apoptosis of AMs. 44-Ant-44 also significantly prolonged the survival of treated animals. These results suggest that polyamine uptake is a potential target for treatment of PCP.

Original languageEnglish
Pages (from-to)5259-5264
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume53
Issue number12
DOIs
StatePublished - Dec 2009

Fingerprint

Pneumocystis Pneumonia
Polyamines
Ants
Alveolar Macrophages
Diamines
Apoptosis
Benzene
Therapeutic Uses
Exudates and Transudates
Sprague Dawley Rats
Pneumonia
Air
Pathology
Lung
Infection

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Liao, C. P., Phanstiel IV, O., Lasbury, M. E., Zhang, C., Shao, S., Durant, P. J., ... Lee, C-H. (2009). Polyamine transport as a target for treatment of Pneumocystis pneumonia. Antimicrobial Agents and Chemotherapy, 53(12), 5259-5264. https://doi.org/10.1128/AAC.00662-09

Polyamine transport as a target for treatment of Pneumocystis pneumonia. / Liao, Chung Ping; Phanstiel IV, Otto; Lasbury, Mark E.; Zhang, Chen; Shao, Shoujin; Durant, Pamela J.; Cheng, Bi Hua; Lee, Chao-Hung.

In: Antimicrobial Agents and Chemotherapy, Vol. 53, No. 12, 12.2009, p. 5259-5264.

Research output: Contribution to journalArticle

Liao, CP, Phanstiel IV, O, Lasbury, ME, Zhang, C, Shao, S, Durant, PJ, Cheng, BH & Lee, C-H 2009, 'Polyamine transport as a target for treatment of Pneumocystis pneumonia', Antimicrobial Agents and Chemotherapy, vol. 53, no. 12, pp. 5259-5264. https://doi.org/10.1128/AAC.00662-09
Liao CP, Phanstiel IV O, Lasbury ME, Zhang C, Shao S, Durant PJ et al. Polyamine transport as a target for treatment of Pneumocystis pneumonia. Antimicrobial Agents and Chemotherapy. 2009 Dec;53(12):5259-5264. https://doi.org/10.1128/AAC.00662-09
Liao, Chung Ping ; Phanstiel IV, Otto ; Lasbury, Mark E. ; Zhang, Chen ; Shao, Shoujin ; Durant, Pamela J. ; Cheng, Bi Hua ; Lee, Chao-Hung. / Polyamine transport as a target for treatment of Pneumocystis pneumonia. In: Antimicrobial Agents and Chemotherapy. 2009 ; Vol. 53, No. 12. pp. 5259-5264.
@article{26e429ca55944197a1714d31333438ec,
title = "Polyamine transport as a target for treatment of Pneumocystis pneumonia",
abstract = "Polyamine levels are greatly increased in alveolar macrophages (AMs) during Pneumocystis pneumonia (PCP), leading to increased production of H 2O2, which causes AMs to undergo apoptosis. One of the mechanisms by which polyamine levels in AMs are elevated is enhanced uptake of exogenous polyamines. In this study, the possibility of targeting polyamine uptake as a treatment for PCP was examined. Four anthracene- and one benzene-polyamine conjugates that are potential polyamine transport inhibitors, including N1-anthracen-9-ylmethyl-butane-1,4-diamine; N-(4-aminobutyl)-N- anthracen-9-ylmethylbutane-1,4-diamine; N-[4-(4-aminobutylamino) butyl]-N-anthracen-9-ylmethylbutane-1,4-diamine; N-(4-amino-butyl)-N′-(10- {[4-(4-aminobutylamino) butylamino]-methyl}anthracen-9-ylmethyl)butane-1,4- diamine (44-Ant-44); and benzene-polyamine conjugate N-(4-amino-butyl)-N′- (4-{[4-(4-amino-butylamino)butylamino]-methyl}benzyl)butane-1,4-diamine (44-Bn-44), were tested. Compounds 44-Ant-44 and 44-Bn-44 were found to have a very low toxicity to AMs in vitro and were evaluated for their therapeutic effect on PCP in vivo. Sprague-Dawley rats infected with P. carinii for 28 days were intranasally instilled with 50 μl of a 1 mMsolution of 44-Bn-44 or 44-Ant-44 every 2 days. Twenty-one days after initiation of the treatment, three to five rats from each group were sacrificed and examined for lung pathology, organism burden, and apoptosis of AMs. Both 44-Bn-44 and 44-Ant-44 reduced organism burdens; however, only 44-Ant-44 decreased the severity of the infection with reduced lung inflammation, increased clearance of exudates, increased air space, and decreased apoptosis of AMs. 44-Ant-44 also significantly prolonged the survival of treated animals. These results suggest that polyamine uptake is a potential target for treatment of PCP.",
author = "Liao, {Chung Ping} and {Phanstiel IV}, Otto and Lasbury, {Mark E.} and Chen Zhang and Shoujin Shao and Durant, {Pamela J.} and Cheng, {Bi Hua} and Chao-Hung Lee",
year = "2009",
month = "12",
doi = "10.1128/AAC.00662-09",
language = "English",
volume = "53",
pages = "5259--5264",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Polyamine transport as a target for treatment of Pneumocystis pneumonia

AU - Liao, Chung Ping

AU - Phanstiel IV, Otto

AU - Lasbury, Mark E.

AU - Zhang, Chen

AU - Shao, Shoujin

AU - Durant, Pamela J.

AU - Cheng, Bi Hua

AU - Lee, Chao-Hung

PY - 2009/12

Y1 - 2009/12

N2 - Polyamine levels are greatly increased in alveolar macrophages (AMs) during Pneumocystis pneumonia (PCP), leading to increased production of H 2O2, which causes AMs to undergo apoptosis. One of the mechanisms by which polyamine levels in AMs are elevated is enhanced uptake of exogenous polyamines. In this study, the possibility of targeting polyamine uptake as a treatment for PCP was examined. Four anthracene- and one benzene-polyamine conjugates that are potential polyamine transport inhibitors, including N1-anthracen-9-ylmethyl-butane-1,4-diamine; N-(4-aminobutyl)-N- anthracen-9-ylmethylbutane-1,4-diamine; N-[4-(4-aminobutylamino) butyl]-N-anthracen-9-ylmethylbutane-1,4-diamine; N-(4-amino-butyl)-N′-(10- {[4-(4-aminobutylamino) butylamino]-methyl}anthracen-9-ylmethyl)butane-1,4- diamine (44-Ant-44); and benzene-polyamine conjugate N-(4-amino-butyl)-N′- (4-{[4-(4-amino-butylamino)butylamino]-methyl}benzyl)butane-1,4-diamine (44-Bn-44), were tested. Compounds 44-Ant-44 and 44-Bn-44 were found to have a very low toxicity to AMs in vitro and were evaluated for their therapeutic effect on PCP in vivo. Sprague-Dawley rats infected with P. carinii for 28 days were intranasally instilled with 50 μl of a 1 mMsolution of 44-Bn-44 or 44-Ant-44 every 2 days. Twenty-one days after initiation of the treatment, three to five rats from each group were sacrificed and examined for lung pathology, organism burden, and apoptosis of AMs. Both 44-Bn-44 and 44-Ant-44 reduced organism burdens; however, only 44-Ant-44 decreased the severity of the infection with reduced lung inflammation, increased clearance of exudates, increased air space, and decreased apoptosis of AMs. 44-Ant-44 also significantly prolonged the survival of treated animals. These results suggest that polyamine uptake is a potential target for treatment of PCP.

AB - Polyamine levels are greatly increased in alveolar macrophages (AMs) during Pneumocystis pneumonia (PCP), leading to increased production of H 2O2, which causes AMs to undergo apoptosis. One of the mechanisms by which polyamine levels in AMs are elevated is enhanced uptake of exogenous polyamines. In this study, the possibility of targeting polyamine uptake as a treatment for PCP was examined. Four anthracene- and one benzene-polyamine conjugates that are potential polyamine transport inhibitors, including N1-anthracen-9-ylmethyl-butane-1,4-diamine; N-(4-aminobutyl)-N- anthracen-9-ylmethylbutane-1,4-diamine; N-[4-(4-aminobutylamino) butyl]-N-anthracen-9-ylmethylbutane-1,4-diamine; N-(4-amino-butyl)-N′-(10- {[4-(4-aminobutylamino) butylamino]-methyl}anthracen-9-ylmethyl)butane-1,4- diamine (44-Ant-44); and benzene-polyamine conjugate N-(4-amino-butyl)-N′- (4-{[4-(4-amino-butylamino)butylamino]-methyl}benzyl)butane-1,4-diamine (44-Bn-44), were tested. Compounds 44-Ant-44 and 44-Bn-44 were found to have a very low toxicity to AMs in vitro and were evaluated for their therapeutic effect on PCP in vivo. Sprague-Dawley rats infected with P. carinii for 28 days were intranasally instilled with 50 μl of a 1 mMsolution of 44-Bn-44 or 44-Ant-44 every 2 days. Twenty-one days after initiation of the treatment, three to five rats from each group were sacrificed and examined for lung pathology, organism burden, and apoptosis of AMs. Both 44-Bn-44 and 44-Ant-44 reduced organism burdens; however, only 44-Ant-44 decreased the severity of the infection with reduced lung inflammation, increased clearance of exudates, increased air space, and decreased apoptosis of AMs. 44-Ant-44 also significantly prolonged the survival of treated animals. These results suggest that polyamine uptake is a potential target for treatment of PCP.

UR - http://www.scopus.com/inward/record.url?scp=71249130797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71249130797&partnerID=8YFLogxK

U2 - 10.1128/AAC.00662-09

DO - 10.1128/AAC.00662-09

M3 - Article

C2 - 19805570

AN - SCOPUS:71249130797

VL - 53

SP - 5259

EP - 5264

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 12

ER -